查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954802

连续性肾臟替代疗法 (CRRT) 耗材市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测 (2026–2034)

Continuous Renal Replacement Therapy (CRRT) Consumables Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

连续性肾臟替代疗法 (CRRT) 耗材市场成长驱动因子

受急性肾损伤 (AKI) 发病率上升、先进肾臟护理解决方案的广泛应用以及全球重症监护基础设施的扩建等因素的推动，全球连续性肾臟替代疗法 (CRRT) 耗材市场正经历稳步增长。 预计2025年市场规模将达到9.1256亿美元，从2026年的9.8412亿美元增长至2034年的18.6784亿美元，预测期内（2026-2034年）复合年增长率（CAGR）为8.34%。

2025年，北美以38.22%的市占率领先。 这得益于其完善的医疗保健基础设施以及人们对先进肾臟替代疗法的日益关注。 连续性肾臟替代疗法（CRRT）耗材包括治疗过程中使用的基本医疗产品，例如透析液、置换液、过滤器、抗凝血剂和导管。这些产品对于严重肾功能不全患者的治疗至关重要，尤其是对于入住加护病房（ICU）的患者。 市场动态 市场驱动因素 急性肾损伤 (AKI) 发生率上升 全球急性肾损伤 (AKI) 病例显着增加是推动市场成长的主要因素。临床研究表明，每年有数百万人遭受 AKI 的困扰，其中低收入和中等收入国家承受的负担尤其沉重。重症患者通常需要持续性肾臟替代疗法 (CRRT) 而非间歇性透析，增加了对血液滤过器、透析液和血路管路等耗材的需求。

此外，产品审批数量的增加和新产品的上市也促进了 CRRT 的应用。 CRRT 设备和一次性产品的技术进步提高了重症监护室 (ICU) 治疗的效率和可近性。

市场限制因子

高昂的成本和专业的医疗基础设施要求

CRRT 手术复杂，需要专业的 ICU 医疗基础设施和训练有素的医护人员。 持续的耗材成本，例如置换液、透析液、过滤器和体外循环迴路，加重了医疗机构的经济负担。

在发展中国家，熟练医护人员短缺和高昂的手术费用阻碍了CRRT的普及。一次CRRT治疗费用高达数百美元，在资源匮乏的环境中难以负担。

市场机会

转向基于价值的肾臟护理模式

医院扩大采用以价值为导向的护理模式，专注于改善患者预后和优化ICU住院时间。这一趋势推动了对先进、易用且高效的CRRT耗材的需求。

製造商正在研发新一代过滤器和液体管理系统，旨在提高解毒能力、最大限度地减少治疗中断并简化临床工作流程。 旨在提升医疗专业人员专业技能的数位整合工具和培训工具也正在实施中。

市场挑战

缺乏标准化治疗方案

与传统透析不同，CRRT 的治疗方案在剂量、治疗选择和液体成分方面因机构而异。这种全球标准化的缺失使产品设计复杂化，并延缓了监管批准。它也会使治疗效果的评估和临床试验的标准化更加困难，可能阻碍其更广泛的应用。

市场趋势

技术进步与数位化整合

CRRT 耗材市场正受益于自动化和数位化医疗的整合。具有追踪功能的智慧耗材能够即时监测治疗参数和使用情况。 製造商正致力于开发能够简化治疗流程并提高安全性的系统。

医院与供应商之间建立策略伙伴关係，进行批量采购，以及采用订阅式耗材供应模式，也正在成为成本管理策略。

细分市场分析

依类型

  • 置换液（主要细分市场）

该细分市场占最大的市场占有率，预计将保持最高的复合年增长率。置换液对于在连续性肾臟替代疗法 (CRRT) 期间维持体液和电解质平衡至关重要。败血症相关急性肾损伤 (AKI) 和多重器官衰竭病例的增加正在推动需求成长。

  • 透析液（成长第二快的细分市场）
  • 过滤器
  • 导管
  • 其他

全球 CRRT 手术数量的增加正在增强所有耗材类别的需求。

依治疗方式

  • 连续性静脉-静脉血液透析滤过（CVVHDF）－占比最大

CVVHDF结合了扩散和对流机制，以实现全面的溶质清除。 它广泛用于治疗代谢紊乱严重的危重患者。

  • 连续性静脉-静脉血液滤过 (CVVH) - 市占率第二
  • 连续性静脉-静脉血液透析 (CVVHD)
  • 慢速连续性超滤 (SCUF)

由于其卓越的运作效率和临床疗效，CVVHDF 仍然是首选的治疗方法。

区域展望

北美

北美将在 2025 年以 38.22% 的市占率引领全球市场。由于完善的重症监护室 (ICU) 基础设施、有利的报销政策以及肾臟护理意识的不断提高，该地区市场规模在 2026 年将达到 3.3072 亿美元。政府措施和人力资源发展计划正在进一步推动该地区的成长。

欧洲

欧洲在2024年占了相当大的市场占有率，预计到2034年将保持稳定成长。强劲的研究投入、人口老化以及肾臟疾病盛行率的上升是主要的成长驱动因素。

亚太地区

预计亚太地区在预测期内将达到最高的复合年增长率。快速老化和肾臟疾病发病率的上升正在推动中国和印度等国家对连续性肾臟替代疗法（CRRT）的需求。

拉丁美洲、中东和非洲

由于肾臟照护的投资增加，拉丁美洲正经历温和成长。 同时，在中东和非洲，在重症监护设施的改善和对先进肾臟治疗方法的认识提高的推动下，该地区正经历温和扩张。

目录

第一章 引言

第二章 摘要整理

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章 主要发现

  • 主要国家末期肾病患病率
  • 主要公司新产品发布
  • 产业主要发展动态（併购、合作等）
  • 肾臟替代疗法技术进步

第五章 全球持续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 依类型划分
    • 透析液
    • 置换液
    • 滤镜
    • 导管
    • 其他
  • 市场分析、洞察与预测 - 依模式划分
    • 慢速连续超滤 (SCUF)
    • 连续慢速血液滤过 (CVVH)
    • 连续性慢速血液透析 (CVVHD)
    • 连续慢速血液透析滤过 (CVVHDF)
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美连续性肾臟替代疗法市场分析、洞察与预测持续性肾臟替代疗法 (CRRT) 耗材市场 (2021-2034)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 其他欧洲国家/地区

第七章：亚太地区持续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2021-2034)

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 其他亚太地区

第八章：拉丁美洲持续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第九章 中东和非洲连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 其他中东和非洲国家

第10章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Baxter
    • B Braun SE
    • Fresenius Medical Care AG &Co. KGaA
    • Asahi Kasei Medical Co., Ltd.(Asahi Kasei Corporation)
    • NIPRO
    • TORAY MEDICAL CO, LTD.(TORAY INDUSTRIES, INC.)
    • Nikkiso Co., Ltd.
    • Medtronic
    • Other Prominent Players
Product Code: FBI113670

Growth Factors of Continuous Renal Replacement Therapy (CRRT) consumables Market

The global Continuous Renal Replacement Therapy (CRRT) consumables market is witnessing steady growth due to the increasing prevalence of acute kidney injury (AKI), rising adoption of advanced renal care solutions, and expanding intensive care infrastructure worldwide. The market was valued at USD 912.56 million in 2025 and is projected to grow from USD 984.12 million in 2026 to USD 1,867.84 million by 2034, registering a CAGR of 8.34% during the forecast period (2026-2034).

In 2025, North America dominated the market with a 38.22% share, supported by strong healthcare infrastructure and growing awareness regarding advanced kidney replacement therapies.

CRRT consumables include essential medical products such as dialysates, replacement fluids, filters, anticoagulants, and catheters used during continuous renal replacement therapy. These products are critical in managing patients with severe kidney dysfunction, particularly those admitted to intensive care units (ICUs).

Market Dynamics

Market Drivers

Increasing Incidence of Acute Kidney Injury (AKI)

A significant rise in acute kidney injury cases globally is a key growth driver. According to clinical findings, millions of individuals suffer from AKI annually, with a high burden in low- and middle-income countries. Critically ill patients often require continuous renal replacement therapy rather than intermittent dialysis, thereby increasing demand for consumables such as hemofilters, dialysate fluids, and bloodline sets.

Additionally, growing product approvals and launches are boosting adoption. Technological advancements in CRRT machines and disposables are making therapy more efficient and accessible in ICUs.

Market Restraints

High Cost and Specialized Infrastructure Requirements

CRRT procedures are complex and require specialized ICU infrastructure and trained healthcare professionals. The recurring cost of consumables-including replacement fluids, dialysates, filters, and extracorporeal circuits-adds to the financial burden on healthcare facilities.

In developing economies, limited availability of skilled staff and high procedural costs restrict widespread adoption. A single CRRT session can cost several hundred dollars, limiting affordability in resource-constrained settings.

Market Opportunities

Shift Toward Value-Based Renal Care

Hospitals are increasingly adopting value-based care models focused on improving patient outcomes while optimizing ICU stays. This trend is generating demand for advanced, easy-to-use, and efficient CRRT consumables.

Manufacturers are introducing next-generation filters and fluid management systems designed to enhance toxin removal, minimize therapy interruptions, and simplify clinical workflows. Digital integration and training tools are also being implemented to improve healthcare professional expertise.

Market Challenges

Lack of Standardized Treatment Protocols

Unlike conventional dialysis, CRRT practices vary significantly across institutions in terms of dosing, modality selection, and fluid composition. This lack of global standardization complicates product design and slows regulatory approvals. It also makes outcome measurement and clinical trial standardization more challenging, potentially hindering broader adoption.

Market Trends

Technological Advancements and Digital Integration

The CRRT consumables market is benefiting from automation and digital health integration. Smart consumables with tracking capabilities allow real-time monitoring of therapy parameters and usage. Manufacturers are focusing on systems that simplify therapy delivery and improve safety.

Strategic partnerships between hospitals and suppliers for bulk procurement and subscription-based consumable supply models are also emerging as cost-control strategies.

Segmentation Analysis

By Type

  • Replacement Solutions (Dominant Segment)

This segment holds the largest market share and is expected to maintain the highest CAGR. Replacement solutions are critical for maintaining fluid and electrolyte balance during CRRT. Increasing cases of sepsis-related AKI and multi-organ failure are driving demand.

  • Dialysates (Second-Fastest Growing)
  • Filters
  • Catheters
  • Others

The rising number of CRRT procedures globally is strengthening demand across all consumable categories.

By Modality

  • Continuous Venovenous Hemodiafiltration (CVVHDF) - Largest Share

CVVHDF combines diffusion and convection mechanisms, offering comprehensive solute clearance. It is widely used for critically ill patients with complex metabolic imbalances.

  • Continuous Venovenous Hemofiltration (CVVH) - Second Leading
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Slow Continuous Ultrafiltration (SCUF)

CVVHDF remains the preferred modality due to its superior operational efficiency and clinical effectiveness.

Regional Outlook

North America

North America led the global market in 2025 with a 38.22% share. The regional market reached USD 330.72 million in 2026, supported by strong ICU infrastructure, favorable reimbursement policies, and growing awareness about renal care. Government initiatives and workforce development programs are further boosting regional growth.

Europe

Europe held a substantial share in 2024 and is expected to show steady growth through 2034. Strong research initiatives, an aging population, and increasing kidney disease prevalence are key growth contributors.

Asia Pacific

Asia Pacific is projected to register the highest CAGR during the forecast period. The rapidly aging population and increasing incidence of kidney disorders are expanding the demand for CRRT procedures in countries such as China and India.

Latin America & Middle East & Africa

Latin America is experiencing gradual growth due to increased investments in renal care. Meanwhile, the Middle East & Africa region is witnessing moderate expansion driven by improving ICU facilities and awareness regarding advanced renal therapies.

Competitive Landscape

The market is consolidated, with leading players focusing on product innovation, partnerships, and geographic expansion. Major companies include:

  • Baxter
  • B. Braun SE
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • NIPRO
  • TORAY MEDICAL CO., LTD.
  • Nikkiso Co., Ltd.
  • Medtronic

These companies leverage strong distribution networks, advanced product portfolios, and regulatory approvals to maintain competitive advantages.

Conclusion

The global CRRT consumables market, valued at USD 912.56 million in 2025, is projected to grow to USD 984.12 million in 2026 and reach USD 1,867.84 million by 2034, at a CAGR of 8.34%. Growth is driven by rising acute kidney injury cases, increasing ICU admissions, and technological advancements in renal care solutions. Although high costs and infrastructure challenges persist, ongoing innovations and the global shift toward value-based renal care are expected to sustain long-term market expansion.

Segmentation

By Type

  • Dialysates
  • Replacement Solutions
  • Filters
  • Catheters
  • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

  • North America (By Type, Modality, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Modality, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Modality, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Modality, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Modality, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of End Stage Renal Disease, Key Countries
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.4. Technological Advancements in Renal Replacement Therapy

5. Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Dialysates
    • 5.1.2. Replacement Solutions
    • 5.1.3. Filters
    • 5.1.4. Catheters
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Dialysates
    • 6.1.2. Replacement Solutions
    • 6.1.3. Filters
    • 6.1.4. Catheters
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.3.1. U.K.
    • 6.3.2. Germany
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Scandinavia
    • 6.3.7. Rest of Europe

7. Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Dialysates
    • 7.1.2. Replacement Solutions
    • 7.1.3. Filters
    • 7.1.4. Catheters
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. Southeast Asia
    • 7.3.6. Rest of Asia Pacific

8. Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Dialysates
    • 8.1.2. Replacement Solutions
    • 8.1.3. Filters
    • 8.1.4. Catheters
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Brazil
    • 8.3.2. Mexico
    • 8.3.3. Rest of Latin America

9. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Dialysates
    • 9.1.2. Replacement Solutions
    • 9.1.3. Filters
    • 9.1.4. Catheters
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. GCC
    • 9.3.2. South Africa
    • 9.3.3. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Baxter
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. B Braun SE
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Fresenius Medical Care AG & Co. KGaA
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. NIPRO
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. TORAY MEDICAL CO, LTD. (TORAY INDUSTRIES, INC.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Nikkiso Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Medtronic
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Other Prominent Players

List of Tables

  • Table 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 9: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 12: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 15: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 18: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025 & 2034
  • Figure 4: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Region, 2025 & 2034
  • Figure 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 7: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 8: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 9: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country, 2025
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2025 & 2034
  • Figure 30: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2025
  • Figure 31: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 32: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2025
  • Figure 33: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Share (%), By Company, 2025